Therefore, SIRT2 can be involved in metabolic disorder-related inflammation and oxidative stress and participate in the pathological process of metabolic disorder-related diseases, rendering SIRT2 a target for the clinical treatment of diseases. This evidence concerns the gene SIRT2 and metabolic disease.